NASDAQ$ASTH
Astrana Health Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Reported strong third quarter performance with revenue up and a 15% adjusted EBITDA margin.
Apollo Medical Holdings reported a strong third quarter with a 10% increase in total revenue and a 34% increase in capitated revenue compared to the previous year. The company achieved a 15% adjusted EBITDA margin and narrowed its full-year guidance range. They also announced the intent to acquire assets relating to Community Family Care Medical Group and partnerships with two other provider groups, expanding their value-based care business.
- Total revenue increased by 10% year-over-year.
- Capitated revenue increased by 34% year-over-year.
- Adjusted EBITDA margin was 15%.
- The company announced the intent to acquire assets relating to Community Family Care Medical Group.
Headline financials
Revenue & EPS history
Astrana Health · Revenue · Quarterly
$348M
Forward guidance
ApolloMed narrowed its full-year 2023 guidance, which includes the impact of excluded assets held by APC. These ranges are based on the Company’s existing business, current view of existing market conditions, and assumptions for the year ending December 31, 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+0.7%
Avg return
Earnings day
-2.1%
Avg return
5 days after
+2.1%
Avg return
30 days after
40%
23 / 57 earnings
Positive
+83.3%
Q3 2011
Best reaction
-40.5%
Q2 2012
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +29.4% | +22.5% | +20.6% | |
| Q3 2025 | -23.4% | -29.4% | -33.8% | |
| Q1 2025 | -11.1% | -20.8% | -24.5% | |
| Q4 2024 | -26.8% | +5.0% | +16.1% | |
| Q3 2024 | -21.1% | -27.9% | -30.4% | |
| Q2 2024 | -1.4% | -1.8% | +0.1% | |
| Q1 2024 | -0.7% | +1.5% | +8.0% | |
| Q4 2023 | +2.3% | +1.8% | -1.9% | |
| Q3 2023 | +9.3% | +2.9% | +13.4% | |
| Q2 2023 | +4.2% | +3.5% | -17.4% | |
| Q1 2023 | +5.4% | +7.0% | -0.8% | |
| Q4 2022 | +6.9% | +5.2% | +15.2% | |
| Q3 2022 | +8.4% | +8.9% | -14.5% | |
| Q2 2022 | -4.3% | -11.0% | -29.3% | |
| Q1 2022 | -0.5% | -5.4% | -26.4% | |
| Q4 2021 | -2.0% | -11.0% | -7.0% | |
| Q3 2021 | +14.7% | +30.5% | +0.8% | |
| Q2 2021 | -11.8% | -10.7% | -12.9% | |
| Q1 2021 | +4.5% | +4.7% | +10.9% | |
| Q4 2020 | +9.1% | +8.8% | +8.3% | |
| Q3 2020 | -1.2% | -1.6% | +0.5% | |
| Q2 2020 | +1.8% | +2.4% | +7.9% | |
| Q1 2020 | -10.4% | -11.6% | +13.1% | |
| Q4 2019 | -12.9% | -24.0% | +7.0% | |
| Q3 2019 | -2.9% | -0.9% | +25.0% | |
| Q2 2019 | -5.0% | +4.8% | +31.1% | |
| Q1 2019 | -1.2% | -4.3% | -29.7% | |
| Q4 2018 | -6.4% | -8.3% | -6.9% | |
| Q3 2018 | +26.3% | +4.0% | -4.6% | |
| Q2 2018 | -13.7% | -23.3% | -32.2% | |
| Q4 2017 | +10.8% | -6.3% | +2.1% | |
| Q1 2018 | +10.8% | -6.3% | +2.1% | |
| Q3 2017 | +3.9% | +3.9% | +140.0% | |
| Q2 2017 | +0.0% | +0.0% | -10.5% | |
| Q1 2017 | +0.0% | +6.7% | +36.7% | |
| Q1 2016 | +4.0% | +4.0% | +0.0% | |
| Q3 2016 | -4.8% | — | — | |
| Q2 2016 | -12.9% | — | — | |
| Q1 2015 | -6.5% | — | — | |
| Q3 2015 | -3.2% | — | — | |
| Q2 2015 | +0.0% | — | — | |
| Q2 2014 | +15.6% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | +1.6% | — | — | |
| Q2 2013 | +13.5% | — | — | |
| Q1 2013 | -13.3% | — | — | |
| Q4 2012 | -2.2% | — | — | |
| Q3 2012 | -9.1% | — | — | |
| Q2 2012 | -40.5% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | +83.3% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2011 | -0.5% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q3 2010 | +19.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | -2.1% | — | — | |
| Q4 2009 | +9.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro